Market Place
Sourcing Support
Forge Biologics Launches FUEL™ AAV Manufacturing Platform
02 Oct 2024 //
BUSINESSWIRE
Forge Biologics to Support MDA’s Kickstart Program
10 Sep 2024 //
CONTRACT PHARMA
Forge Biologics Announces Planned CEO Succession
10 Sep 2024 //
BUSINESSWIRE
Ajinomoto Announces the Approval of the 32nd Drug Product at their San Diego
12 Jun 2024 //
PRESS RELEASE
Ajinomoto Bio-Pharma Services Garners Six `CDMO Leadership Awards
12 Mar 2024 //
PR NEWSWIRE
New acquisition to support global gene therapy manufacturing
15 Nov 2023 //
EUROPEAN PHARMACEUTICAL REVIEW
Ajinomoto Bio-Pharma Services Makes Leadership Changes at U.S. Facility
18 May 2023 //
CONTRACT PHARMA
Ajinomoto Bio-Pharma Services Receives FDA Approval for High Potency Fill Line
19 Apr 2023 //
PR NEWSWIRE
Ajinomoto Bio-Pharma Services Awarded Three ‘CDMO Leadership Awards’
14 Mar 2023 //
PRESS RELEASE
Ajinomoto Services Successfully Develops Highly Functional Ancestral RNA Ligase
22 Feb 2023 //
PR NEWSWIRE
Ajinomoto and Exelixis Enter Into Agreement to Develop Antibody-Drug Conjugates
10 Jan 2023 //
PR NEWSWIRE
Ajinomoto Bio-Pharma Services Awarded Two ‘CMO Leadership Awards’
03 Mar 2022 //
PRESS RELEASE
Tony O`Neill Joins Ajinomoto Bio-Pharma` Leadership Team as VP of Compliance
25 Jan 2022 //
PRNEWSWIRE
Aji Bio-Pharma to Add High Speed Fill/Finish Line to its San Diego Facility
25 May 2021 //
PHARMTECH
Ajinomoto expands manufacturing tie-up with AstraZeneca
06 Apr 2021 //
FIERCE PHARMA
Ajinomoto Bio-Pharma Services Expands Manufacturing Agreement with AstraZeneca
30 Mar 2021 //
PRNEWSWIRE
Ajinomoto, Bright Peak Enter Immunocytokines Research Pact
30 Mar 2021 //
CONTRACTPHARMA
Bright Peak Therapeutics and Ajinomoto to create novel immunocytokines
25 Mar 2021 //
BIOSPECTRUMASIA
Ajinomoto Bio-Pharma expands Humanigen Lenzilumab agreement
27 Jan 2021 //
PHARMACEUTICAL-TECHNOLOGY
Ajinomoto Bio-Pharma Services and Revance Announce Manufacturing Agreement
22 Dec 2020 //
PRNEWSWIRE
Ajinomoto Bio-Pharma Services and Revance Announce Manufacturing Agreement
22 Dec 2020 //
PRNEWSWIRE
Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement With Humanigen
09 Nov 2020 //
DRUG-DEV
Ajinomoto Bio-Pharma Services` AJIPHASE Technology Receives FDA Approval
06 Oct 2020 //
PRNEWSWIRE
Aji Bio-Pharma Expands Small Molecule Mfg. Capabilities
12 Aug 2020 //
CONTRACTPHARMA
Ajinomoto Bio-Pharma Services Introduces AJILITY Fast Track for Drug Product
30 Jun 2020 //
PRNEWSWIRE
Ajinomoto Bio-Pharma Services Completes Acquisition of Granules OmniChem
01 Jun 2020 //
PRNEWSWIRE
Ajinomoto Services Signs Manufacturing Agreement with Humanigen for Lenzilumab
27 May 2020 //
PRNEWSWIRE
